Skip to main content

High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward.

Publication ,  Journal Article
Furst, DE; Nash, R; Sullivan, KM; Saccardi, R; McSweeney, P
Published in: J Rheumatol
December 2004

Duke Scholars

Published In

J Rheumatol

ISSN

0315-162X

Publication Date

December 2004

Volume

31

Issue

12

Start / End Page

2331 / 2335

Location

Canada

Related Subject Headings

  • Treatment Outcome
  • Severity of Illness Index
  • Scleroderma, Systemic
  • Risk Assessment
  • Male
  • Immunotherapy
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Follow-Up Studies
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Furst, D. E., Nash, R., Sullivan, K. M., Saccardi, R., & McSweeney, P. (2004). High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward. J Rheumatol, 31(12), 2331–2335.
Furst, Daniel E., Richard Nash, Keith M. Sullivan, Riccardo Saccardi, and Peter McSweeney. “High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward.J Rheumatol 31, no. 12 (December 2004): 2331–35.
Furst DE, Nash R, Sullivan KM, Saccardi R, McSweeney P. High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward. J Rheumatol. 2004 Dec;31(12):2331–5.
Furst, Daniel E., et al. “High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward.J Rheumatol, vol. 31, no. 12, Dec. 2004, pp. 2331–35.
Furst DE, Nash R, Sullivan KM, Saccardi R, McSweeney P. High dose immunotherapy with stem cell rescue in severe systemic sclerosis: an idea that is moving forward. J Rheumatol. 2004 Dec;31(12):2331–2335.

Published In

J Rheumatol

ISSN

0315-162X

Publication Date

December 2004

Volume

31

Issue

12

Start / End Page

2331 / 2335

Location

Canada

Related Subject Headings

  • Treatment Outcome
  • Severity of Illness Index
  • Scleroderma, Systemic
  • Risk Assessment
  • Male
  • Immunotherapy
  • Humans
  • Hematopoietic Stem Cell Transplantation
  • Follow-Up Studies
  • Female